JPMorgan names heads for healthcare, tech investment banking
Sept 19 (Reuters) -JPMorgan Chase JPM.N announced on Thursday leadership changes in a push to strengthen its healthcare and technology investment banking, according to an internal memo seen by Reuters.
Ben Carpenter and Jeremy Meilman would be the global co-heads of healthcare investment banking, while Chris Grose and Greg Mendelson have been named global co-heads of the technology investment banking, according to the memo.
Investment banking has been a bright spot for the major Wall Street firms, as more companies look to raise capital through debt or equity offerings and engage in takeover deals driven by growing confidence in the U.S. economic outlook.
JPMorgan beat estimates for second-quarter profit in July, helped by a resurgence in dealmaking and strong capital markets.
Its investment banking revenue grew 46% to $2.5 billion for the quarter ended in June, compared with a low base a year earlier.
Carpenter, an industry veteran, rejoined JPMorgan from Citigroup C.N in 2021 as a healthcare mergers and acquisitions (M&A) banker and Meilman has been with the bank for nearly two decades, as per the memo.
Grose joined JPMorgan's technology and diversified industries team in 2005, while Mendelson, who has been at the firm since 2015, served as the vice chair of investment banking in his most recent role at the firm.
"Our clients and colleagues will benefit greatly from their networks, strategic insights and market expertise," Doug Petno and Filippo Gori, co-heads of global banking, said in the memo.
The largest bank in the U.S. also named Mike Gaito as the global chair of healthcare investment banking and Pankaj Goel, Madhu Namburi and Drago Rajkovic as global chairs of technology investment banking.
Reporting by Nupur Anand in New York and Pritam Biswas in Bengaluru; Editing by Mohammed Safi Shamsi
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
